title: Spironolactone.
abstract: Therapeutic Reviews aim to provide essential independent information for health professionals about drugs used in palliative and hospice care. Additional content is available on www.palliativedrugs.com. Country-specific books (Hospice and Palliative Care Formulary USA, and Palliative Care Formulary, British and Canadian editions) are also available and can be ordered from www.palliativedrugs.com. The series editors welcome feedback on the articles (hq@palliativedrugs.com).
authors.affiliation: University of Nottingham, Nottingham, United Kingdom.
authors.forename: Laura
authors.initials: L
authors.lastname: Carone
authors.affiliation: Kirkwood Hospice, Huddersfield, United Kingdom.
authors.forename: Stephen G
authors.initials: SG
authors.lastname: Oxberry
authors.affiliation: Oxford University, Oxford, United Kingdom.
authors.forename: Robert
authors.initials: R
authors.lastname: Twycross
authors.affiliation: Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.
authors.forename: Sarah
authors.initials: S
authors.lastname: Charlesworth
authors.affiliation: Mylan School of Pharmacy, Duquesne University, Pittsburgh, Pennsylvania, USA.
authors.forename: Mary
authors.initials: M
authors.lastname: Mihalyo
authors.affiliation: University of Nottingham, Nottingham, United Kingdom. Electronic address: andrew.wilcock@nottingham.ac.uk.
authors.forename: Andrew
authors.initials: A
authors.lastname: Wilcock
mesh_terms: D004232:Diuretics / Q000494:pharmacology / Q000627:therapeutic use*; D004487:Edema / Q000188:drug therapy*; D017051:Hospice Care; D006801:Humans; D010166:Palliative Care; D013148:Spironolactone / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D004232:Diuretics; D013148:Spironolactone